Cargando…

Anti-Inflammatory Activity of Citrus bergamia Derivatives: Where Do We Stand?

Inflammatory diseases affect a large portion of the worldwide population, and chronic inflammation is a major risk factor for several dangerous pathologies. To limit the side effects of both synthetic and biological anti-inflammatory drugs, the use of herbal medicines, nutraceuticals and food supple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferlazzo, Nadia, Cirmi, Santa, Calapai, Gioacchino, Ventura-Spagnolo, Elvira, Gangemi, Sebastiano, Navarra, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274179/ https://www.ncbi.nlm.nih.gov/pubmed/27669206 http://dx.doi.org/10.3390/molecules21101273

Ejemplares similares

Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role?
por: Cirmi, Santa, et al.
Publicado: (2016)

Bergamottin and 5-Geranyloxy-7-methoxycoumarin Cooperate in the Cytotoxic Effect of Citrus bergamia (Bergamot) Essential Oil in Human Neuroblastoma SH-SY5Y Cell Line
por: Maugeri, Alessandro, et al.
Publicado: (2021)

Anticancer Potential of Citrus Juices and Their Extracts: A Systematic Review of Both Preclinical and Clinical Studies
por: Cirmi, Santa, et al.
Publicado: (2017)

Chemopreventive Agents and Inhibitors of Cancer Hallmarks: May Citrus Offer New Perspectives?
por: Cirmi, Santa, et al.
Publicado: (2016)

Mechanisms Underlying the Anti-Tumoral Effects of Citrus bergamia Juice
por: Delle Monache, Simona, et al.
Publicado: (2013)

In vitro effect of bergamot (Citrus bergamia) juice against cagA-positive and-negative clinical isolates of Helicobacter pylori
por: Filocamo, Angela, et al.
Publicado: (2015)

Citrus bergamia Juice Extract Attenuates β-Amyloid-Induced Pro-Inflammatory Activation of THP-1 Cells Through MAPK and AP-1 Pathways
por: Currò, Monica, et al.
Publicado: (2016)

Correction: Mechanisms Underlying the Anti-Tumoral Effects of Citrus bergamia Juice
por: Delle Monache, Simona, et al.
Publicado: (2018)

Citrus bergamia essential oil: from basic research to clinical application
por: Navarra, Michele, et al.
Publicado: (2015)

Clinical Pharmacology of Citrus aurantium and Citrus sinensis for the Treatment of Anxiety
por: Mannucci, Carmen, et al.
Publicado: (2018)

Neuroprotective Effect of Bergamot Juice in 6-OHDA-Induced SH-SY5Y Cell Death, an In Vitro Model of Parkinson’s Disease
por: Ferlazzo, Nadia, et al.
Publicado: (2020)

A Flavonoid-Rich Extract of Mandarin Juice Counteracts 6-OHDA-Induced Oxidative Stress in SH-SY5Y Cells and Modulates Parkinson-Related Genes
por: Cirmi, Santa, et al.
Publicado: (2021)

Effectiveness of Citrus Fruits on Helicobacter pylori
por: Mandalari, Giuseppina, et al.
Publicado: (2017)

Cytokine Network Involvement in Subjects Exposed to Benzene
por: Minciullo, Paola Lucia, et al.
Publicado: (2014)

Citrus bergamia: Kinetics of Antimicrobial Activity on Clinical Isolates
por: Quirino, Angela, et al.
Publicado: (2022)

Cannabinoids, Blood–Brain Barrier, and Brain Disposition
por: Calapai, Fabrizio, et al.
Publicado: (2020)

Where Do We Stand?
Publicado: (1891)

Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)

Moringin from Moringa Oleifera Seeds Inhibits Growth, Arrests Cell-Cycle, and Induces Apoptosis of SH-SY5Y Human Neuroblastoma Cells through the Modulation of NF-κB and Apoptotic Related Factors
por: Cirmi, Santa, et al.
Publicado: (2019)

Mechanisms Underlying the Anti-Inflammatory Activity of Bergamot Essential Oil and Its Antinociceptive Effects †
por: Lombardo, Giovanni Enrico, et al.
Publicado: (2020)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)

Pixel Detectors ... where do we stand?
por: Wermes, Norbert
Publicado: (2019)

Laser accelerators : where do we stand
por: Lawson, J D
Publicado: (1985)

Renormalization schemes: where do we stand?
por: Ward, B F L
Publicado: (1990)

Barrett's Esophagus: Where Do We Stand?
por: Al Madi, Majid A.
Publicado: (2009)

Maximizing neuroprotection: where do we stand?
por: Kuffler, Damien P
Publicado: (2012)

LHC Access - Where do we Stand
por: Ninin, P, et al.
Publicado: (2006)

Where do we stand with IPF treatment?
por: Albera, C, et al.
Publicado: (2013)

Genetics of Keratoconus: Where Do We Stand?
por: Abu-Amero, Khaled K., et al.
Publicado: (2014)

Cricoid pressure: Where do we stand?
por: Bhatia, Nidhi, et al.
Publicado: (2014)

Combating Malaria: Where do We Stand?
por: Coats, Mamie T
Publicado: (2016)

Where Do We Stand in Preventive Medicine?
por: Robertson, Wm.
Publicado: (1921)

Bevacizumab in Glaucoma: Where do We Stand?
por: Khanna, Anjani
Publicado: (2012)

Schistosomiasis vaccines: where do we stand?
por: Tebeje, Biniam Mathewos, et al.
Publicado: (2016)

Dupuytren’s disease: where do we stand?
por: Grazina, Rita, et al.
Publicado: (2019)

Telemedicine in India: Where do we stand?
por: Chellaiyan, Vinoth G., et al.
Publicado: (2019)

Imaging of the spine: Where do we stand?
por: Nouh, Mohamed R
Publicado: (2019)

Autoimmune Myopathies: Where Do We Stand?
por: Simon, Jean-Philippe, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gbcoop991cb61v4pg0baj29hsi